Literature DB >> 6187823

Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.

C J Liang-Takasaki, N Grossman, L Leive.   

Abstract

Differences in the O-antigen polysaccharide structure of lipopolysaccharide were previously shown to affect the rate of phagocytosis of Salmonellae strains by the murine macrophage-like cell line J774. Phagocytosis required a serum factor(s) that is labile to heat (56 degrees C for 30 min) and to zymosan treatment, which indirectly suggested the participation of C. We now show, using guinea pig serum, that these bacteria activate C3 at different rates, and this activation is proportional to the later rate of phagocytosis. Activation is predominantly via the alternative pathway, because C4 is not consumed and the reaction proceeds equally well in the serum of C4-deficient guinea pigs. Because the extent of activation of C3 and the subsequent rate of phagocytosis are inversely proportional to virulence, we propose that virulence of a strain may be influenced by the ability of the polysaccharide structure of its lipopolysaccharide to activate the alternative pathway of C, destining it for subsequent phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors:  D Pilz; T Vocke; J Heesemann; V Brade
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 2.  Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Authors:  Raphael Simon; Myron M Levine
Journal:  Hum Vaccin Immunother       Date:  2012-02-28       Impact factor: 3.452

3.  Interactions of F1 fractions from different strains of Paracoccidioides brasiliensis with human complement and with human neutrophils.

Authors:  L S Crott; Y M Lucisano-Valim; C L Silva; J E Barbosa
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 4.  Lipopolysaccharide O-antigens-bacterial glycans made to measure.

Authors:  Chris Whitfield; Danielle M Williams; Steven D Kelly
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

5.  Bactericidal and opsonizing effects of normal serum on mutant strains of Salmonella typhimurium.

Authors:  M F Shaio; H Rowland
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

7.  The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children.

Authors:  Calman A MacLennan; Esther N Gondwe; Chisomo L Msefula; Robert A Kingsley; Nicholas R Thomson; Sarah A White; Margaret Goodall; Derek J Pickard; Stephen M Graham; Gordon Dougan; C Anthony Hart; Malcolm E Molyneux; Mark T Drayson
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  The role of O-antigen polysaccharide in the activation of neutrophils by lipopolysaccharides of Salmonella species.

Authors:  O Rasool; N A Nnalue; C Jarstrand
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Activation of complement system by porins extracted from Salmonella typhimurium.

Authors:  F Galdiero; M A Tufano; L Sommese; A Folgore; F Tedesco
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.

Authors:  R W Vreede; J H Marcelis; J Verhoef
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.